| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/JSO.23945 |
| P698 | PubMed publication ID | 26074130 |
| P2093 | author name string | Leonardo Tamariz | |
| Dido Franceschi | |||
| Eli Avisar | |||
| Danny Yakoub | |||
| Rahul Gadde | |||
| Alan Livingstone | |||
| Mena Hanna | |||
| P2860 | cites work | Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis | Q27496690 |
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
| The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone | Q33577629 | ||
| Identification of prognostic factors and surgical indications for metastatic gastric cancer | Q33755032 | ||
| Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer | Q34366342 | ||
| Liver resections in metastatic gastric cancer | Q34394426 | ||
| Trends in long-term survival following liver resection for hepatic colorectal metastases | Q34523502 | ||
| Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? | Q34574521 | ||
| Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer | Q34722336 | ||
| Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes | Q35422126 | ||
| Chemotherapy and radiotherapy in the management of gastric cancer | Q36284129 | ||
| Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma | Q36405952 | ||
| Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. | Q36674050 | ||
| Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer | Q36706401 | ||
| Chemotherapy and resection for gastric cancer with synchronous liver metastases | Q36759239 | ||
| Metachronous hepatic metastases from gastric carcinoma: a multicentric survey | Q37378209 | ||
| Role of metastasectomy on overall survival of patients with metastatic gastric cancer | Q37559226 | ||
| Hepatic resection for metastatic breast cancer: a systematic review | Q37899463 | ||
| Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature | Q37926527 | ||
| Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? | Q38246199 | ||
| Surgery for stage IV gastric cancer | Q39382802 | ||
| Therapeutic significance of palliative operations for gastric cancer for survival and quality of life | Q43700328 | ||
| Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy | Q43878962 | ||
| Significance of palliative gastrectomy for late-stage gastric cancer patients | Q44681408 | ||
| The rise in metastasectomy across cancer types over the past decade | Q48463139 | ||
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. | Q51811363 | ||
| Metastasectomy for synchronous solitary non-small cell lung cancer metastases. | Q52876995 | ||
| Defining palliative surgery in patients receiving noncurative resections for gastric cancer. | Q53339442 | ||
| Achieving R0 resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?1 1No competing interests declared | Q57846714 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 38-45 | |
| P577 | publication date | 2015-06-12 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | Metastatic gastric cancer (MGC) patients: Can we improve survival by metastasectomy? A systematic review and meta-analysis | |
| P478 | volume | 112 |
| Q36040347 | BET inhibition as a new strategy for the treatment of gastric cancer |
| Q92593106 | Clinical Characteristics and Prognosis of Gastrointestinal Metastases in Solid Tumor Patients: A Retrospective Study and Review of Literatures |
| Q59335006 | Conversion surgery for gastric cancer patients: A review |
| Q28080545 | Hepatic metastases from gastric cancer: A surgical perspective |
| Q49197397 | Long-term survival after gastrectomy and metastasectomy for gastric cancer with synchronous bone metastasis |
| Q41701825 | Metastatic gastric cancer from breast carcinoma: A report of 78 cases |
| Q90321326 | Surgical management of metastatic gastric cancer: moving beyond the guidelines |
| Q64109929 | The role of surgical resection before palliative chemotherapy in advanced gastric cancer |
| Q61809751 | The survival benefit of palliative gastrectomy and/or metastasectomy in gastric cancer patients with synchronous metastasis: a population-based study using propensity score matching and coarsened exact matching |
| Q89354598 | [Resection of advanced esophagogastric adenocarcinoma : Extended indications] |
| Q89815247 | [Therapeutic approach in oligometastatic gastric and esophageal cancer] |
Search more.